Spatial transcriptomics of TAMs infiltration in NSCLC reveals that TAMs enrichment in the TME is relevant to tumor cell resistance to ICB immunotherapy regardless of its PD-L1 status, which is mediated by CD27, ITGAM, and CCL5 gene expression upregulation within tumor compartment 62. The gene discussed is CD274; the disease is neoplasm.